Breast cancer and ovarian cancer are both associated with mutations and/or overexpression/amplification in certain genes (e.g. BRCA1, BRCA2, PIK3C, ERBB2, etc.)and aberrations in related pathways, which exhibits a risk of co-occurrence in women (41–43). This evidence concerns the gene BRCA2 and breast cancer.